130 Other chronobiological changes that have been identified

are phase-delay,131 decreased selleck inhibitor amplitude of variables,41 and possible changes in ultradian rhythms.132 Some facts cannot be interpreted either in favor or against the hypothesis of changes in chronobiology in mood disorders. For example, only a very small proportion of subjects became depressed during free-running experiments. Also, severe Inhibitors,research,lifescience,medical psychiatric manifestations during jet lag occur only very rarely. Finally, electroconvulsive therapy can have acute and immediate beneficial effects in melancholia, either by a release of endogenous compounds or by a form of resetting of cerebral or biological clocks activities. There are also arguments against a direct role of biological clocks in mood disorders. Inhibitors,research,lifescience,medical Seasonal affective disorder Seasonal affective disorder (SAD) is among disorders with a circannual period. This was recently described by Rosenthal and his collaborators.133 They defined it as a syndrome characterized by recurrent depression that occurs annually, generally at the same time each year, for several years. They Inhibitors,research,lifescience,medical described 29 patients, most of them presenting depression from early fall during all winter,

with hypersomnia, hyperphagia, and carbohydrate craving. The temperature pattern was normal during depression,134,135 or showed a decrease in amplitude.136 This mood disorder is considered to have a high prevalence, which somehow does not correspond to the impression of some psychiatrists, perhaps because they do not recognize SAD, or because Inhibitors,research,lifescience,medical SAD patients consult psychiatrists less than do other dépressives. The pathophysiology of SAD might involve a phase-delay of circadian rhythms.77 Light therapy is useful,137 as are selective serotonin reuptake inhibitors (SSRIs). Premenstrual syndromes The DSM-III-R label of late luteal phase dysphoric disorder was replaced by the actual

wording of premenstrual dysphoric disorder (PMDD) in the DSM-IV 138 In the ICD-10, 139 premenstrual tension or premenstrual syndrome is listed under the disorders Inhibitors,research,lifescience,medical of the genitourinary system. The term premenstrual syndrome is often used to describe the less severe presentations of the syndrome. These different terms describe a series of symptoms and signs Phosphoprotein phosphatase in women of reproductive age that occur during the luteal phase of their cycle and disappear on the first day or days of menstruation. In some women, these symptoms are limited to a few days before menstruation, while in others, they start at the time of ovulation. The clinical manifestations vary in severity, PMDD being characterized by quite severe changes in mood, with depression, anxiety, and suspiciousness; women tend to be irritable, cry, and feel desperate, with the impression of losing control of their existence. One of the diagnostic criteria for PMDD is impairment of quality of life.